- Tonix Pharmaceuticals Holding Corp to Host KOL Webinar TranscriptJan 31, 2024
- Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference TranscriptOct 19, 2023
- Tonix Pharmaceuticals Holding Corp At The June 1st Virtual Investor Summit TranscriptJun 01, 2023
- Tonix Pharmaceuticals Holding Corp At Investor Summit (Virtual) TranscriptMar 29, 2023
- Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio TranscriptFeb 23, 2023
- Tonix Pharmaceuticals Holding Corpinterview with Dr. Seth Lederman, MD, and CEO TranscriptFeb 13, 2023
- Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies TranscriptFeb 01, 2023
- Tonix Pharmaceuticals Holding Corp at EBD Group Biotech Showcase TranscriptJan 10, 2023
- Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference TranscriptOct 26, 2022
- Tonix Pharmaceuticals Holding Corp at Q2 Investor Summit TranscriptMay 04, 2022
- Tonix Pharmaceuticals Holding Corp at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 27, 2022
- Tonix Pharmaceuticals Holding Corp at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 21, 2022
- Tonix Pharmaceuticals Holding Corp at Biotechnology Industry Organization (BIO) CEO & Investor Conference (Virtual) - Virtual Presentation TranscriptFeb 14, 2022
- Tonix Pharmaceuticals Holding Corp at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 23, 2021
- Tonix Pharmaceuticals Holding Corp at ICR Virtual Conference TranscriptJan 14, 2021
- Tonix Pharmaceuticals Holding Corp Business Update TranscriptDec 07, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Network Virtual Conference TranscriptAug 06, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase TranscriptApr 29, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase TranscriptApr 22, 2020
- Tonix Pharmaceuticals Holding Corp at Tarsier Capital Management Spring Summit TranscriptMar 25, 2020
- Tonix Pharmaceuticals Holding Corp at Noble Financial Emerging Growth Investor Conference TranscriptFeb 18, 2020
Tonix Pharmaceuticals Holding Corp at ICR Virtual Conference Transcript
Good morning, everyone. Thank you for joining us today for the ICR conference. I'm Peter Vozzo, Managing Director at Westwicke ICR. And it's my pleasure to introduce Seth Lederman, President and Chief Executive Officer of Tonix Pharmaceuticals. Tonix is a clinical-stage biopharmaceutical company focused on central nervous system and immunology product candidates.
Seth is going to provide an overview of the company, which we will then follow with the Q&A session. (Conference Instructions)
With that, I'll turn it over to Seth.
Thank you, Peter, and thanks to the ICR organizers. It's a pleasure to be here. It's a very exciting time for Tonix. It's the best time in Tonix history. We have a lot of interesting news. And for those who haven't been following this story, we just announced a positive Phase 3 study in fibromyalgia in December.
So we are mid-Phase 3 in that program. We're recruiting in a second
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)